LR Health & Beauty reported its financial results for 2024. Sales increased to $327.9 million in 2024, representing a year-over-year boost of 4.6%. This increase was driven primarily by the realignment of the career plan and successful launches of the company’s cosmetics line and intestinal metabolism treatment.

LR Health & Beauty honored its company legacy and history as it celebrated its 40th anniversary. The company reflected on its product and sales innovations in 2024, including its LR Health Mission and LR ZEITGARD Signature, as important foundations for future growth.

LR Health & Beauty reported a 7.2% increase in sales in Q3 2024. Total revenue in the quarter reached $73.32 million in sales. The company attributed this revenue boost primarily to the high demand for its new decorative cosmetics line LR ZEITGARD Signature and a large influx of new sales partners as a result of the realignment of its career plan.

LR Health & Beauty SE announced its financial results for the third quarter of 2024. Sales during the quarter increased by 7.2% to $73.2 million. EBITDA during the quarter increased to $7.7 million.

LR Health & Beauty SE announced its financial results for the second quarter of 2024, reporting sales of $78 million, a 2.6% increase from the previous year’s quarter. With these results, the company achieved $158 million in sales for the first half of the year, citing its new product launches, including the LR Health Mission and the LR Body Mission, as significant contributors to its positive sales performance.

LR Health & Beauty SE shareholder Quadriga Capital announced it has won private equity firm Evoco as a major investor in the company. This capital infusion will provide more financial backing that will allow the company to continue driving toward its strategic initiatives.

LR Global Holding GmbH announced its financial results for the fourth quarter and full year 2023. Revenue in 2023 reached $302 million, a 2.6% increase over 2022 and within the company’s previously released guidance. EBITDA for the full year was $38.7 million. Fourth quarter 2023 revenue was $77.4 million, a 2.7% decline from the same […]

LR Global Holding GmbH, the parent company of LR Health & Beauty, released preliminary figures that show a 5% year-over-year sales increase for the first quarter of 2023. This positive trajectory is a result of a strategic realignment initiative that the company began in summer of 2022.

In an official award ceremony hosted by the German Design Council, LR Health & Beauty’s Zeitgard Pro Cosmetic Device was recognized with the German Design Award 2023 in the Bath and Wellness category.

LR Health & Beauty announced the launch of ZEITGARD PRO Cosmetic Device, a cosmetic device for home use with interchangeable beauty tools. Each tool provides a different function, including deep-pore facial cleansing and the promotion of anti-aging.

LR Group reported its full year financial report for 2021, announcing EBITDA at the upper end of its earnings forecast and a 4% increase in group sales.   The company prepared for future growth by strengthening its capital market capability and establishing LR Health & Beauty SE as the new parent company of the LR Group. […]

LR Global Holding GmbH, the social selling parent company for direct selling organization LR Health & Beauty, reported a 4% year-over-year increase in group sales in fiscal 2021, bringing total group sales to EUR 296.2 million. Fourth quarter sales reached EUR 75.5 million, a near-record result for the company.   EBITDA for 2021 was up over […]